MX2019013799A - Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo. - Google Patents

Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.

Info

Publication number
MX2019013799A
MX2019013799A MX2019013799A MX2019013799A MX2019013799A MX 2019013799 A MX2019013799 A MX 2019013799A MX 2019013799 A MX2019013799 A MX 2019013799A MX 2019013799 A MX2019013799 A MX 2019013799A MX 2019013799 A MX2019013799 A MX 2019013799A
Authority
MX
Mexico
Prior art keywords
novel peptide
pharmaceutical composition
treatment
active ingredient
eye diseases
Prior art date
Application number
MX2019013799A
Other languages
English (en)
Spanish (es)
Inventor
Taegon Baik
Taek- Soo Kim
Dae- Seong LIM
Deuk- Young GOO
Original Assignee
Yuyu Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma Inc filed Critical Yuyu Pharma Inc
Publication of MX2019013799A publication Critical patent/MX2019013799A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2019013799A 2017-05-17 2018-05-17 Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo. MX2019013799A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20170061250 2017-05-17
PCT/KR2018/005673 WO2018225961A1 (ko) 2017-05-17 2018-05-17 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물

Publications (1)

Publication Number Publication Date
MX2019013799A true MX2019013799A (es) 2020-08-13

Family

ID=64566301

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013799A MX2019013799A (es) 2017-05-17 2018-05-17 Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.

Country Status (13)

Country Link
US (1) US12037415B2 (enExample)
EP (1) EP3643723B1 (enExample)
JP (2) JP7680824B2 (enExample)
KR (2) KR102287226B1 (enExample)
CN (1) CN110945012A (enExample)
AU (1) AU2018281617B2 (enExample)
BR (1) BR112019024040A2 (enExample)
CA (1) CA3063842A1 (enExample)
ES (1) ES2982308T3 (enExample)
MX (1) MX2019013799A (enExample)
RU (1) RU2766160C2 (enExample)
SG (1) SG11201912110YA (enExample)
WO (1) WO2018225961A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2766160C2 (ru) * 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
TWI865470B (zh) * 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
BR112021023477A2 (pt) * 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório
KR20210104460A (ko) * 2020-02-17 2021-08-25 주식회사 아이바이오코리아 고체상 합성법을 이용한 펩타이드의 제조 방법
CA3170606A1 (en) * 2020-03-05 2021-09-30 Wonsang YU Treatment of inflammatory diseases with peptides and pharmaceutical compositions
KR102593936B1 (ko) * 2021-12-13 2023-10-27 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
EP4450079A4 (en) * 2021-12-13 2025-12-10 Eyebiokorea Inc COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION COMPRISING A NEW PEPTIDE
KR102587729B1 (ko) * 2023-02-27 2023-10-12 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
KR102673860B1 (ko) * 2023-08-10 2024-06-12 (주)케어젠 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US20090131303A1 (en) 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
MY180581A (en) 2011-05-27 2020-12-02 Allergan Inc A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
JP2015500213A (ja) * 2011-11-30 2015-01-05 ザイジェン インフラメーション リミテッド 眼乾燥症候群を処置するためのｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
KR101555296B1 (ko) 2013-12-10 2015-09-23 인제대학교 산학협력단 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물
KR101948156B1 (ko) 2013-12-10 2019-02-14 인제대학교 산학협력단 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물
KR101721059B1 (ko) * 2014-12-26 2017-03-30 주식회사 아이바이오코리아 안구 표면 질환 예방 또는 치료용 약학조성물
KR101690539B1 (ko) 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
TWI675851B (zh) 2015-12-14 2019-11-01 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 短合成胜肽及其用途
KR101798183B1 (ko) * 2016-04-08 2017-11-15 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
EP3539559B1 (en) 2016-04-08 2020-08-26 Eyebio Korea Collagen type ii alpha-1-based peptide for use in the treatment of macular degeneration
KR101795653B1 (ko) 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR20180074928A (ko) 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물
RU2766160C2 (ru) 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
TWI865470B (zh) 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
CA3170606A1 (en) 2020-03-05 2021-09-30 Wonsang YU Treatment of inflammatory diseases with peptides and pharmaceutical compositions

Also Published As

Publication number Publication date
RU2019141646A3 (enExample) 2021-07-28
JP7680824B2 (ja) 2025-05-21
SG11201912110YA (en) 2020-01-30
CA3063842A1 (en) 2019-12-09
EP3643723A4 (en) 2021-03-31
KR20180126406A (ko) 2018-11-27
ES2982308T3 (es) 2024-10-15
RU2019141646A (ru) 2021-06-17
EP3643723A1 (en) 2020-04-29
EP3643723C0 (en) 2024-05-15
US20210024577A1 (en) 2021-01-28
US12037415B2 (en) 2024-07-16
JP2023098936A (ja) 2023-07-11
WO2018225961A1 (ko) 2018-12-13
CN110945012A (zh) 2020-03-31
RU2766160C2 (ru) 2022-02-08
KR20210097670A (ko) 2021-08-09
KR102287226B1 (ko) 2021-08-11
JP7775250B2 (ja) 2025-11-25
BR112019024040A2 (pt) 2020-09-24
AU2018281617B2 (en) 2022-06-30
KR102498428B1 (ko) 2023-02-20
AU2018281617A1 (en) 2019-12-05
JP2020520372A (ja) 2020-07-09
EP3643723B1 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
MX2016014634A (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
MX2020003534A (es) Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
PH12019500423A1 (en) Pharmaceutical composition
EP4566651A3 (en) Ophthalmic delivery device
WO2017158366A3 (en) Ophthalmic delivery device and ophthalmic drug compositions
PH12017501097A1 (en) Sunitinib formulations and methods for use thereof in treatment of ocular disorders
DOP2017000270A (es) Composiciones farmacéuticas tópicas
PH12017500460A1 (en) Therapeutic agent delivery device with advanceable cannula and needle
AR093247A1 (es) Agente profilactico y/o terapeutico para sintomas conductuales y psicologicos asociados con la enfermedad neurodegenerativa o sintomas impulsivos asociados con enfermedad mental que contiene brexpiprazol o sales del mismo
EP4360709A3 (en) Use of a vegf antagonist to treat angiogenic eye disorders
CR20170293A (es) Derivados de glucagón con estabilidad mejorada
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
MX2020006309A (es) Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis.
MX2018001918A (es) Aplicación cuantitativa periorbital de farmacos oftalmologicos.
MX2021005077A (es) Peptidos y composiciones farmaceuticas para tratar enfermedades oculares.
MX2019015927A (es) Composiciones para administración de fármacos y métodos de uso de las mismas.
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
MX355853B (es) Composicion oftalmica para el tratamiento de infeccion ocular.
WO2016060917A3 (en) Formulations for histatin therapeutics
BR112014009761B8 (pt) Composição de reticulação melhorada entregue por iontoforese, útil para o tratamento de ceratocone
AR092842A1 (es) Tratamiento de enfermedades inflamatorias oculares usando laquinimod
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
MX376622B (es) Composicion farmaceutica oftalmologica.
MX2022006523A (es) Composicion que comprende budesonida para uso oftalmico.